![Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity - Endotext - NCBI Bookshelf Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity - Endotext - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK279143/bin/pharmacother-obesity-Image001.jpg)
Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity - Endotext - NCBI Bookshelf
![Summary of the mechanism of action for FDA/EMA approved anti-obesity drugs. | Download Scientific Diagram Summary of the mechanism of action for FDA/EMA approved anti-obesity drugs. | Download Scientific Diagram](https://www.researchgate.net/publication/354942802/figure/fig2/AS:1074125393121280@1633102858746/Summary-of-the-mechanism-of-action-for-FDA-EMA-approved-anti-obesity-drugs.jpg)
Summary of the mechanism of action for FDA/EMA approved anti-obesity drugs. | Download Scientific Diagram
![Antiobesity Pharmacotherapy: New Drugs and Emerging Targets - Kim - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library Antiobesity Pharmacotherapy: New Drugs and Emerging Targets - Kim - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/db1ac479-f5b5-4456-a57d-b7b4d5682c40/cptclpt2013204-fig-0002-m.jpg)
Antiobesity Pharmacotherapy: New Drugs and Emerging Targets - Kim - 2014 - Clinical Pharmacology & Therapeutics - Wiley Online Library
![The Use of phentermine/topiramate CR (Qsymia ® ) For Chronic Weight Management Stefanie L. Drahuschak PharmD Candidate 2014 October 14, ppt download The Use of phentermine/topiramate CR (Qsymia ® ) For Chronic Weight Management Stefanie L. Drahuschak PharmD Candidate 2014 October 14, ppt download](https://images.slideplayer.com/36/10563066/slides/slide_15.jpg)
The Use of phentermine/topiramate CR (Qsymia ® ) For Chronic Weight Management Stefanie L. Drahuschak PharmD Candidate 2014 October 14, ppt download
![References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology References in Progress and challenges in anti-obesity pharmacotherapy - The Lancet Diabetes & Endocrinology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119070005/2088773964/gr1.jpg)